Evidence map›Paper›PMID 31004415›Full record

ArticleMolecular genetics & genomic medicine2019

Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing.

Dongyi Yu, Kai Zhang, Meiyan Han, Wei Pan, Ying Chen, Yunfeng Wang, Hongyan Jiao, Ling Duan, Qiying Zhu, Xiaojie Song and 7 more

Abstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Dongyi YuGenetic Testing Center, Qingdao Women & Children Hospital, Qingdao University, Qingdao, China.
Kai ZhangGenetic Testing Center, Qingdao Women & Children Hospital, Qingdao University, Qingdao, China.
Meiyan HanGenetic Testing Center, Qingdao Women & Children Hospital, Qingdao University, Qingdao, China.
Wei PanThe Center of Prenatal Diagnosis, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Ying ChenCentral Lab, Wuxi Maternity and Child Health Care Hospital, Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
Yunfeng WangAnnoroad Gene Technology Co., Ltd, Beijing, China.
Hongyan JiaoThe Branch Center of Prenatal Diagnosis, Hebei Maternity and Child Healthcare Hospital, Shijiazhuang, China.
Ling DuanDepartment of Obstetrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Qiying ZhuDepartment of Obstetrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
Xiaojie SongDepartment of Obstetrics and Gynecology, Wuhan Women and Child Care Service Hospital, Wuhan, China.
Yan HongAnnoroad Gene Technology Co., Ltd, Beijing, China.
Chen ChenAnnoroad Gene Technology Co., Ltd, Beijing, China.
Juan WangAnnoroad Gene Technology Co., Ltd, Beijing, China.
Feng HuiAnnoroad Gene Technology Co., Ltd, Beijing, China.
Linzhou HuangAnnoroad Gene Technology Co., Ltd, Beijing, China.ORCID 0000-0002-3990-765X
Chongjian ChenAnnoroad Gene Technology Co., Ltd, Beijing, China.
Yang DuAnnoroad Gene Technology Co., Ltd, Beijing, China.ORCID 0000-0002-5707-513X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExpanding noninvasive prenatal testing (NIPT) to include the detection of fetal subchromosomal copy number variations (CNVs) significantly decreased the sensitivity and specificity. Developing analytic pipeline to achieve high performance in the noninvasive detection of CNVs will largely contribute to the application of CNVs screening in clinical practice.

methodsWe developed the Noninvasively Prenatal Subchromosomal Copy number variation Detection (NIPSCCD) method based on low-pass whole-genome sequencing, and evaluated its efficacy in detecting fetal CNVs and chromosomal aneuploidies with 20,003 pregnant women.

resultsTotally, NIPSCCD identified 36 CNVs, including 29 CNVs consistent and 7 CNVs inconsistent with amniocytes tests. Additionally, seven fetal CNVs identified by amniocytes testing were undetected by NIPSCCD. The sensitivities for detecting CNVs > 10 Mb, 5 Mb-10 Mb, and CNVs < 5 Mb were 91.67%, 100.00%, and 68.42%, respectively. Moreover, NIPSCCD identified 103/ true positive trisomy 21/18/13 cases and 21 false positives, producing an overall 100.00% sensitivity and 99.89% specificity.

conclusionNIPSCCD showed a good performance in detecting fetal subchromosomal CNVs, especially for CNVs >10 Mb, and can be incorporated into the routine NIPT chromosomal aneuploidies screening with high sensitivity and specificity.

Indexed as

AneuploidyDNA Copy Number VariationsAdultChromosome DisordersFemaleHumansMiddle AgedNoninvasive Prenatal TestingPregnancySensitivity and SpecificityWhole Genome Sequencingcell-free DNAchromosome aneuploidyNIPSCCDNIPTsubchromosomal CNVs

Identifiers

PMID31004415
PMCPMC6565572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.